Remission of chronic inflammatory demyelinating polyneuropathy after alemtuzumab (Campath 1H). [electronic resource]
Producer: 20060525Description: 800-2 p. digitalISSN:- 1468-330X
- Adult
- Alemtuzumab
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized
- Antibodies, Neoplasm -- therapeutic use
- Antirheumatic Agents -- therapeutic use
- Drug Resistance
- Female
- Humans
- Immunoglobulins, Intravenous -- therapeutic use
- Polyradiculoneuropathy, Chronic Inflammatory Demyelinating -- drug therapy
- Treatment Outcome
No physical items for this record
Publication Type: Case Reports; Letter
There are no comments on this title.
Log in to your account to post a comment.